Allurion Technologies (ALUR) Free Cash Flow (2022 - 2026)
Allurion Technologies (ALUR) posted Free Cash Flow of -$3.2 million for Q1 2026, up 39.45% on a QoQ basis from -$5.3 million in Q4 2025, and up 65.98% year-over-year from -$1.9 million in Q1 2025.
Allurion Technologies (ALUR) Free Cash Flow (2022 - 2026) Analysis & Trends
Allurion Technologies' Free Cash Flow history runs 5 years deep, the most recent figure standing at -$3.2 million for Q1 2026.
- Quarterly Free Cash Flow rose 65.98% year-over-year to -$3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.7 million (up 48.03% YoY) and the FY2025 annual result came in at -$28.9 million, up 32.54% from the prior year.
- Free Cash Flow was -$3.2 million for Q1 2026 at Allurion Technologies, up from -$5.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$3.2 million in Q1 2026 and bottomed at -$23.2 million in Q3 2023.
- A 5-year average of -$11.1 million and a median of -$9.6 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow sank 132.58% — and 2026, when it soared 65.98%.
- Allurion Technologies' Free Cash Flow stood at -$16.2 million in 2022, then slumped by 37.23% to -$22.2 million in 2023, then surged by 40.3% to -$13.3 million in 2024, then surged by 59.92% to -$5.3 million in 2025, then jumped by 39.45% to -$3.2 million in 2026.
- Business Quant data shows ALUR's Free Cash Flow at -$3.2 million in Q1 2026, -$5.3 million in Q4 2025, and -$6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.22 Mn |
| Mar 31, 2026 | -3.22 Mn |
| Dec 31, 2025 | -5.32 Mn |
| Dec 31, 2025 | -5.32 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Jun 30, 2025 | -7.63 Mn |
| Jun 30, 2025 | -7.63 Mn |
| Mar 31, 2025 | -9.47 Mn |
| Mar 31, 2025 | -9.47 Mn |
| Dec 31, 2024 | -13.27 Mn |
| Dec 31, 2024 | -13.27 Mn |
| Sep 30, 2024 | -12.01 Mn |
| Sep 30, 2024 | -12.01 Mn |
| Jun 30, 2024 | -8.93 Mn |
| Jun 30, 2024 | -8.93 Mn |
| Mar 31, 2024 | -8.70 Mn |
| Mar 31, 2024 | -8.70 Mn |
| Dec 31, 2023 | -22.24 Mn |
| Dec 31, 2023 | -22.24 Mn |